NUCLEOSIDE INFLUX AND EFFLUX IN GUINEA-PIG VENTRICULAR MYOCYTES - INHIBITION BY ANALOGS OF LIDOFLAZINE

被引:22
作者
CONANT, AR [1 ]
JARVIS, SM [1 ]
机构
[1] UNIV KENT,RES SCH BIOSCI,CANTERBURY CT2 7NJ,KENT,ENGLAND
关键词
ADENOSINE TRANSPORT; NITROBENZYTHIOINOSINE; FORMYCIN B; CARDIOMYOCYTES; NA+/NUCLEOSIDE TRANSPORTER (SNST1);
D O I
10.1016/0006-2952(94)90357-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Adenosine influx and formycin B influx and efflux were characterized in guinea-pig ventricular myocytes at 22 degrees. Transport by both modes was saturable and inhibited by nitrobenzylthioinosine (NBMPR), indicating the presence of an equilibrative NBMPR-sensitive nucleoside transporter in the cardiomyocytes. The kinetic constants for influx and efflux of formycin B, a non-metabolized nucleoside, were similar, suggesting that the nucleoside transporter exhibits symmetrical kinetics (apparent K-m 490 +/- 160 and 700 +/- 140 mu M; V-max, 6.5 +/- 1.7 and 3.5 +/- 0.3 nmol/10(6) cells per min for influx and efflux, respectively). No evidence was found of either NBMPR-insensitive equilibrative nucleoside transport or sodium-dependent concentrative nucleoside transport. Inhibition of adenosine influx (apparent K(m)100 +/- 33 mu M), by lidoflazine and the analogues mioflazine, soluflazine and R73-335, gave average K-i values of 730, 100, 64 and 2.9 nM, respectively. These compounds also inhibited formycin B efflux with a similar potency to that of adenosine influx. NBMPR-sensitive nucleoside transport was associated with high affinity binding of NBMPR (apparent K-d similar to 1 nM; 9.6 x 10(5) sites/cell). Specific binding of NBMPR was also inhibited by lidoflazine and its analogues. Mioflazine and soluflazine were 20-30-fold more potent at inhibiting NBMPR-sensitive nucleoside influx in guinea-pig erythrocytes than ventricular myocytes, indicating that the potency of some of the compounds studied is tissue dependent.
引用
收藏
页码:873 / 880
页数:8
相关论文
共 35 条
[1]  
BARROS LF, 1991, J MEMBRANE BIOL, V119, P151
[2]  
BEAR HP, 1990, J PHARM PHARMACOL, V42, P367
[3]   ABSENCE OF BINDING-SITES FOR THE TRANSPORT INHIBITOR NITROBENZYLTHIOINOSINE ON NUCLEOSIDE TRANSPORT-DEFICIENT MOUSE LYMPHOMA-CELLS [J].
CASS, CE ;
KOLASSA, N ;
UEHARA, Y ;
DAHLIGHARLEY, E ;
HARLEY, ER ;
PATERSON, ARP .
BIOCHIMICA ET BIOPHYSICA ACTA, 1981, 649 (03) :769-777
[4]  
CHENG YC, 1973, BIOCHEM PHARMACOL, V23, P3099
[5]  
CLANACHAN AS, 1987, TOPICS PERSPECTIVES, P118, DOI DOI 10.1007/978-3-642-45619-0_10
[6]  
CRONSTEIN BN, 1992, J IMMUNOL, V148, P2201
[7]   PROTECTIVE EFFECTS OF ADENOSINE IN MYOCARDIAL-ISCHEMIA [J].
ELY, SW ;
BERNE, RM .
CIRCULATION, 1992, 85 (03) :893-904
[8]   CARDIOPROTECTIVE EFFECTS OF MIOFLAZINE DURING HYDROGEN NORMOTHERMIC GLOBAL-ISCHEMIA IN THE CANINE HEART [J].
FLAMENG, W ;
XHONNEUX, R ;
VANBELLE, H ;
BORGERS, M ;
VANDEWATER, A ;
WOUTERS, L ;
WIJNANTS, J ;
THONE, F ;
VANDAELE, P ;
JANSSEN, PAJ .
CARDIOVASCULAR RESEARCH, 1984, 18 (09) :528-537
[9]   DIFFERENTIAL INHIBITION OF NUCLEOSIDE TRANSPORT-SYSTEMS IN MAMMALIAN-CELLS BY A NEW SERIES OF COMPOUNDS RELATED TO LIDOFLAZINE AND MIOFLAZINE [J].
GRIFFITH, DA ;
CONANT, AR ;
JARVIS, SM .
BIOCHEMICAL PHARMACOLOGY, 1990, 40 (10) :2297-2303
[10]   NUCLEOSIDE TRANSPORT IN BRUSH-BORDER MEMBRANE-VESICLES FROM HUMAN KIDNEY [J].
GUTIERREZ, MM ;
BRETT, CM ;
OTT, RJ ;
HUI, AC ;
GIACOMINI, KM .
BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1105 (01) :1-9